Vasorelaxation induced by methyl cinnamate, the major constituent of the essential oil of Ocimum micranthum, in rat isolated aorta

The Role of Essential Oils and Their Main Compounds in the Management of Cardiovascular Disease Risk Factors

Cardiovascular diseases (CVDs) are a global health burden that greatly impact patient quality of life and account for a huge number of deaths worldwide. Despite current therapies, several side effects have been reported that compromise patient adherence; thus, affecting therapeutic benefits. In this context, plant metabolites, namely volatile extracts and compounds, have emerged as promising therapeutic agents. Indeed, these compounds, in addition to having beneficial bioactivities, are generally more amenable and present less side effects, allowing better patient tolerance. The present review is an updated compilation of the studies carried out in the last 20 years on the beneficial potential of essential oils, and their compounds, against major risk factors of CVDs. Overall, these metabolites show beneficial potential through a direct effect on these risk factors, namely hypertension, dyslipidemia and diabetes, or by acting on related targets, or exerting general cellular protection. In general, monoterpenic compounds are the most studied regarding hypotensive and anti-dyslipidemic/antidiabetic properties, whereas phenylpropanoids are very effective at avoiding platelet aggregation. Despite the number of studies performed, clinical trials are sparse and several aspects related to essential oil’s features, namely volatility and chemical variability, need to be considered in order to guarantee their efficacy in a clinical setting.

Protective Effects of Phenylpropanoids and Phenylpropanoid-rich Essential Oils on the Cardiovascular System

BACKGROUND

Cardiovascular diseases are the leading cause of global mortality with a tendency to increase due to population ageing as well as an increase in associated risk factors. Although current therapies improve survival rates, they are associated with several side effects, thus justifying the development of novel preventive and/or therapeutic approaches. In this way, plant metabolites such as essential oils have emerged as promising agents due to their biological effects.

OBJECTIVE

Bearing in mind that several essential oils are characterized by high amounts of phenylpropanoids, which may play a crucial role in the activity of these volatile extracts, a comprehensive and systematic review focusing on the cardiovascular effects of phenylpropanoid-rich essential oils is presented.

METHODS

Popular search engines including PubMed, Science Direct, Scopus and Google Scholar were consulted and papers from 2000 onwards were selected. Non-volatile phenylpropanoids were not considered in this review.

RESULTS

A compilation of the current knowledge on this thematic pointed out beneficial effects for volatile phenylpropanoids namely hypotensive, vasorelaxant, antiplatelet aggregation, antidyslipidaemic and antidiabetic, as well as protective properties against ischemia/reperfusion injury and heart hypertrophy.

CONCLUSION

A better understanding of the protective effects of phenylpropanoids on the cardiovascular system is presented, thus paving the way towards future research on plant-based therapies for cardiovascular diseases.

PIEZORESISTIVE STRAIN SENSOR APPLICATION IN EVALUATION OF MOUSE AORTIC MEDIA CUSHIONS EFFECTIVENESS AND SPONTANEOUS MYOGENIC CONTRACTION

The aortic media realized Windkessel vessel functions and maintain sustained ventricle ejection balance during cardiac circle. Wheatstone bridge circuit piezoresistive strain sensor had desirable sensing properties to investigate aortic cushion features. In this study, Wheatstone bridge sensor was used to evaluate quick stretching-induced aortic efficient cushions and spontaneous myogenic contractions. Mice aortic specimens were loosely hooked and stabilized to [Formula: see text][Formula: see text]mm stainless steel pin and strain sensor, whereas the other side was hooked and shows increasing specimen length. Specimen isometric tension and rhythmic spontaneous myogenic contraction were recorded. Isometric tension and spontaneous myogenic response at initial length ([Formula: see text] and ultimate length ([Formula: see text] were evaluated. Aortic specimen significantly eliminated mechanical rigid oscillations. The recovery to baseline time was significantly shortened at [Formula: see text] ([Formula: see text][Formula: see text]ms and [Formula: see text] ms at [Formula: see text] and [Formula: see text], respectively, but [Formula: see text][Formula: see text]ms and [Formula: see text][Formula: see text]ms in no-load test). High Ca[Formula: see text] incubation prolonged the recovery time to baseline at [Formula: see text] and [Formula: see text] ([Formula: see text][Formula: see text]ms and [Formula: see text][Formula: see text]ms, respectively) and suggested Ca[Formula: see text] decreased efficient cushion. Moreover, strain sensor successfully recorded the enhanced rhythmic spontaneous myogenic contractions in isometric specimen. Wheatstone bridge circuit sensor reflected the significance of efficient cushions under mechanical preload, which absolutely captured rhythmic myogenic contractions of mice aortic specimen.

Medicinal plants used to treat snakebite in Central America: Review and assessment of scientific evidence

ETHNOPHARMACOLOGICAL RELEVANCE

Every year between 1.2 and 5.5 million people worldwide are victims of snakebites, with about 400,000 left permanently injured. In Central America an estimated 5500 snakebite cases are reported by health centres, but this is likely to be an underestimate due to unreported cases in rural regions. The aim of this study is to review the medicinal plants used traditionally to treat snakebites in seven Central American countries: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama.

MATERIALS AND METHODS

A literature search was performed on published primary data on medicinal plants of Central America and those specifically pertaining to use against snakebites. Plant use reports for traditional snakebite remedies identified in primary sources were extracted and entered in a database, with data analysed in terms of the most frequent numbers of use reports. The scientific evidence that might support the local uses of the most frequently reported species was also examined.

RESULTS

A total of 260 independent plant use reports were recorded in the 34 sources included in this review, encompassing 208 species used to treat snakebite in Central America. Only nine species were reported in at least three studies: Cissampelos pareira L., Piper amalago L., Aristolochia trilobata L., Sansevieria hyacinthoides (L.) Druce, Strychnos panamensis Seem., Dorstenia contrajerva L., Scoparia dulcis L., Hamelia patens Jacq., and Simaba cedron Planch. Genera with the highest number of species used to treat snakebite were Piper, Aristolochia, Hamelia, Ipomoea, Passiflora and Peperomia. The extent of the scientific evidence available to understand any pharmacological basis for their use against snakebites varied between different plant species.

CONCLUSION

At least 208 plant species are traditionally used to treat snakebite in Central America but there is a lack of clinical research to evaluate their efficacy and safety. Available pharmacological data suggest different plant species may target different symptoms of snakebites, such as pain or anxiety, although more studies are needed to further evaluate the scientific basis for their use.